A detailed history of Essex Investment Management CO LLC transactions in Biodesix Inc stock. As of the latest transaction made, Essex Investment Management CO LLC holds 971,197 shares of BDSX stock, worth $1.34 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
971,197
Previous 968,617 0.27%
Holding current value
$1.34 Million
Previous $1.48 Million 16.68%
% of portfolio
0.32%
Previous 0.29%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$1.53 - $1.96 $3,947 - $5,056
2,580 Added 0.27%
971,197 $1.73 Million
Q2 2024

Aug 12, 2024

BUY
$1.21 - $1.71 $52,033 - $73,535
43,003 Added 4.65%
968,617 $1.48 Million
Q1 2024

May 03, 2024

BUY
$1.35 - $2.12 $17,103 - $26,858
12,669 Added 1.39%
925,614 $1.32 Million
Q4 2023

Feb 07, 2024

SELL
$1.2 - $2.13 $124,041 - $220,173
-103,368 Reduced 10.17%
912,945 $1.68 Million
Q3 2023

Nov 09, 2023

SELL
$1.04 - $1.74 $16,536 - $27,666
-15,900 Reduced 1.54%
1,016,313 $1.68 Million
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.88 $276,148 - $463,534
246,561 Added 31.38%
1,032,213 $1.27 Million
Q1 2023

May 04, 2023

BUY
$1.52 - $2.5 $619,640 - $1.02 Million
407,658 Added 107.85%
785,652 $1.46 Million
Q4 2022

Feb 02, 2023

SELL
$0.98 - $2.3 $28 - $66
-29 Reduced 0.01%
377,994 $869,000
Q3 2022

Nov 14, 2022

BUY
$1.24 - $2.89 $468,748 - $1.09 Million
378,023 New
378,023 $480,000
Q3 2021

Nov 09, 2021

SELL
$6.6 - $12.78 $654,951 - $1.27 Million
-99,235 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$12.14 - $20.35 $98,807 - $165,628
-8,139 Reduced 7.58%
99,235 $1.31 Million
Q1 2021

May 12, 2021

BUY
$16.87 - $31.21 $1.81 Million - $3.35 Million
107,374 New
107,374 $2.18 Million

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.